Medicare Enrolled

Dr. Maziar Lalezary, MD

Retina Specialist (Ophthalmology) Physician · Beverly Hills, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8383 WILSHIRE BLVD STE 440, Beverly Hills, CA 90211
3105715026
In practice since 2007 (18 years)
NPI: 1710170253 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lalezary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lalezary? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lalezary

Dr. Maziar Lalezary is a retina specialist physician in Beverly Hills, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lalezary performed 11,484 Medicare services across 2,635 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lalezary received a total of $5,842 from 31 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lalezary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 28% volume in CA $5,842 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,484
Medicare services
Top 28% in CA for retina specialist (ophthalmology) physician
2,635
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~638 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
5,520 $29 $71
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,583 $104 $269
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,362 $34 $149
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
731 $31 $222
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
623 $97 $776
Aflibercept eye injection (Eylea) 569 $687 $1,286
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
299 $21 $109
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
183 $129 $377
Triamcinolone acetonide injection, 1 mg
An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose without preservatives.
124 $3 $15
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
95 $37 $240
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
95 $55 $134
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
68 $237 $524
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
61 $74 $262
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
57 $127 $310
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
35 $107 $365
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
30 $295 $3,075
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
29 $456 $2,026
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
20 $212 $2,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,842
Total received (2018-2024)
Avg $835/year across 7 years
Top 30% in CA for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,842 (82.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,000 (17.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,966
2023
$1,005
2022
$418
2021
$128
2020
$384
2019
$503
2018
$1,438

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EyePoint Pharmaceuticals US, Inc.
$1,019
Regeneron Healthcare Solutions, Inc.
$398
Cardinal Health 110 LLC
$150
Astellas Pharma US Inc
$150
Sandoz Inc.
$56
Genentech USA, Inc.
$52
Mallinckrodt Hospital Products Inc.
$33
Tarsus Pharmaceuticals, Inc.
$32
Biogen, Inc.
$30
Coherus Biosciences Inc.
$28
Amgen Inc.
$18
Top 3 companies account for 79.7% of 2024 payments
All-time payments by company (2018-2024) ›
EyePoint Pharmaceuticals US, Inc.
$1,078
Dutch Ophthalmic Research Center (International) B.V.
$850
Regeneron Healthcare Solutions, Inc.
$771
Novartis Pharmaceuticals Corporation
$413
Apellis Pharmaceuticals, Inc.
$286
VisionCare Inc.
$241
Genentech USA, Inc.
$224
ABBVIE INC.
$207
Alimera Sciences, Inc.
$193
Astellas Pharma US Inc
$183
KVK-Tech, Inc.
$175
Alcon Vision LLC
$171
Cardinal Health 110 LLC
$150
Oyster Point Pharma, Inc.
$146
Horizon Pharma plc
$124
Coherus Biosciences Inc.
$110
Mallinckrodt Hospital Products Inc.
$108
Horizon Therapeutics plc
$75
Sandoz Inc.
$56
Carl Zeiss Meditec AG
$39
Tarsus Pharmaceuticals, Inc.
$32
Biogen, Inc.
$30
Heidelberg Engineering, Inc.
$29
Eyevance Pharmaceuticals LLC
$29
Harrow Eye, LLC
$22
Omeros Corporation
$19
Amgen Inc.
$18
Optos, Inc.
$17
Thea Pharma Inc.
$16
Allergan, Inc.
$15
Boston Scientific Corporation
$15
Top 3 companies account for 46.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BYOOVIZ · Cimerli · Constellation · DEXYCU · EVA Ophthalmic Surgical System · EYLEA · EYLEA HD · EYP-1901 · Flarex · General - Pain Management · ILUVIEN · Iluvien · Implantable Miniature Telescope · Izervay · Lucentis · None Specified · OZURDEX · Omidria · P200DTx · Simbrinza · Spectralis · Susvimo · Syfovre · TEPEZZA · TEPRO · TYRVAYA · Tobradex ST · Vabysmo · XDEMVY · XEN GLAUCOMA TREATMENT SYSTEM · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a retina specialist physician in Beverly Hills?
Compare retina specialist physicians in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
30
Per 100K population
0.3
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lalezary is a mixed practice specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lalezary experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Lalezary performed 5,520 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lalezary receive payments from pharmaceutical companies?
Yes. Dr. Lalezary received a total of $5,842 from 31 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lalezary's costs compare to other retina specialist physicians in Beverly Hills?
Dr. Lalezary's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lalezary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →